Parallel Advisors, LLC Bolt Biotherapeutics, Inc. Call Options Transaction History

Parallel Advisors, LLC

  • $4.87 Billion
  • Q2 2025

Call Options

1 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2021

Oct 22, 2021
BUY
$11.15 - $18.6 $702 - $1,171
63 New
63 $1,000

Others Institutions Holding BOLT

# of Institutions
3
Shares Held
683K
Call Options Held
0
Put Options Held
0
View Full List

About Bolt Biotherapeutics, Inc.

BOLT Quotes by TradingView
  • Ticker BOLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,641,500
  • Market Cap $193M
  • Description
  • Bolt Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the development of immuno-oncology agents to target tumor cells for elimination by the immune system. The company is developing BDC-1001, a human epidermal growth factor receptor 2 (HER2), which is in Phase I/II clinical trial for the treatment of patients with HER2-e...
More about BOLT
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email